SCHEMBL21652970

SCHEMBL21652970

CCn1cc(NC(=O)c2ccc(F)s2)ccc1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ RXFP1 Q9HBX9 2/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ EPAS1 Q99814 1/20 0.41
▸ KMT2A Q03164 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ PPARG P37231 1/20 0.39
▸ NCOA2 Q15596 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ TP53 P04637 2/20 0.38
▸ PDE10A Q9Y233 1/20 0.38
▸ MAPT P10636 4/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ DAO P14920 1/20 0.37
▸ ESRRG P62508 2/20 0.37
▸ PTPN2 P17706 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21653230 0.85 ALDH1A1 (0.49) NPC1RAB9ARXFP1KMT2AMEN1
SCHEMBL21653238 0.85 SMN1; SMN2 (0.38) NPC1RAB9ARXFP1HIF1AEPAS1
SCHEMBL21653071 0.85 KMT2A (0.49) NPC1RAB9ARXFP1KMT2APOLB
SCHEMBL21653123 0.81 HIF1A (0.41) NPC1RAB9AHIF1AEPAS1KMT2A
SCHEMBL21653240 0.79 ALDH1A1 (0.45) NPC1RAB9ARXFP1KMT2APOLB
SCHEMBL21653250 0.78 ALDH1A1 (0.43) NPC1RAB9ARXFP1KMT2APOLB
SCHEMBL21653229 0.78 RAB9A (0.42) NPC1RAB9AKMT2APOLBMEN1
SCHEMBL21653124 0.77 PPARG (0.40) NPC1RAB9ARXFP1KMT2APOLB
SCHEMBL21653273 0.76 ALDH1A1 (0.46) NPC1RAB9AKMT2APOLBMEN1
SCHEMBL21653203 0.74 SMN1; SMN2 (0.46) RAB9AKMT2APOLBMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020023657-A1 PYRIDIN-2-ONE COMPOUNDS USEFUL AS SMARCA2 ANTAGONISTS Epizyme, Inc. (US) 2020-01-30 — — WO disclosed
Send feedback